SALT LAKE CITY–Idaho Technology, Inc. announced today that it has filed a submission with the U.S. Food and Drug Administration for 510(k) clearance of five additional respiratory pathogens for its FilmArray Respiratory Panel, a user-friendly Multiplex PCR assay currently FDA cleared for 15 respiratory pathogens. The additional five pathogens are: Bordetella pertussis, Chlamydophila pneumoniae, Mycoplasma […]
INDIANAPOLIS — Roche announced today that it has entered into a strategic alliance with Technoclone, a reagent specialist in thrombosis and cardiovascular diagnostics based in Vienna, Austria, to co-develop a complete range of coagulation assays. The alliance supports plans Roche announced in October 2011 to develop a new line of analyzers for the central coagulation […]
Singapore — GE Global Research, the central technology development arm for GE Healthcare and all of GE’s businesses, has signed a Memorandum of Understanding (MOU) with Singapore’s Agency of Science, Technology and Research (A*STAR). This agreement will focus on advancing current medical imaging technologies and diagnostics to enable more accurate, earlier and faster clinical diagnoses […]
London, UK and Ann Arbor, Michigan, US – NextGen Group plc (AIM:NGG) is pleased to announce that its US-subsidiary NextGen Sciences Inc, a leader in biomarker discovery, measurement and qualification, has launched an expanded cerebrospinal fluid (CSF) multiple protein (multiplex) assay, csfdiscovery82, for central nervous system (CNS) biomarker discovery and qualification. The new assay simultaneously […]
SANTA CLARA, Calif. – Agilent Technologies Inc. (NYSE: A) today announced that it has listed its Infinity Series 1200 liquid chromatography systems and 6000 Series mass spectrometry systems as Class I medical devices with the U.S. Food and Drug Administration. “The latest generation of liquid chromatography and mass spec systems that Agilent has registered holds […]
Gaithersburg, Maryland and SEOUL, Korea – Seegene, Inc. (096530:KOSDAQ), a leader in multiplex and molecular diagnostics (MoDx), today announced that it has been awarded a patent by the United States Patent Office (USPTO) for its Dual Priming Oligonucleotide (DPO™) technology.The issuance of this patent underscores Seegene’s leadership in the area of multiplex molecular diagnostics (M-MoDx). […]
CARLSBAD, Calif. — Life Technologies Corporation (NASDAQ: LIFE) today announced that it has signed an agreement with DaAn Gene, a leading Chinese company in molecular in-vitro diagnostics (IVD), to form Life Technologies DaAn Diagnostics, a joint venture diagnostics business in China. The move is expected to contribute to the early diagnosis of oncology, infectious diseases […]
OMAHA, Neb. & THE WOODLANDS, Texas– Transgenomic, Inc. (OTCBB: TBIO) and Power3 Medical Products, Inc. (OTCBB: PWRM) today announced that, following mediation through the offices of the United States District Court for the District of Nebraska, all pre-existing litigations and disputes between the companies have been resolved and terminated, effective immediately. The dispute related to […]
HILDEN and BERLIN, Germany – QIAGEN N.V. and the Max Planck Institute for Infection Biology (MPIIB), Department of Immunology have announced a new collaboration to develop a molecular diagnostic test to assess the risk of an individual with latent tuberculosis (TB) developing active TB disease during their lifetime. Financial terms were not disclosed. Approximately one-third […]
SAN DIEGO — Gen-Probe’s (NASDAQ: GPRO) multiple new product launches are off to a good start and should help drive accelerating, double-digit revenue growth in 2012, according to Carl Hull, Gen-Probe’s chairman and CEO, who will discuss the Company’s 2011 accomplishments and future strategies with investors at JP Morgan’s 30th annual healthcare conference in San […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
